Allarity Therapeutics Inc (ALLR)

$1.14 -0.01 (-0.87%)
Market Cap 18.01M
Revenue (ttm) 0.00
Net Income (ttm) -24.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.12
Volume 76,500
Avg Vol 245,500
Day's Range N/A - N/A
Shares Out 15.80M
Stochastic %K 35%
Beta 0.23
Analysts Sell
Price Target $9.50

Company Profile

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs. The company develops drugs for the personalized treatment of cancer using drug specific companion diagnostics generated by its proprietary drug response predictor technology. Its lead drug candidate includes Stenoparib, a novel dual inhibitor of poly-ADP-ribose polymerase (PARP1/2) that is being evaluated in a phase 2...

Industry: Biotechnology
Sector: Healthcare
Phone: 401 426 4664
Address:
24 School Street, 2nd Floor, Boston, United States
papibaro
papibaro Dec. 12 at 8:12 PM
$ALLR sounds good. Byt I wonder how beneficial that is for allarity. As per chatgpt: I also wonder how accurate it is…
1 · Reply
MichaelSctock
MichaelSctock Dec. 12 at 6:10 PM
$ALLR Jensen is cookin’…. 👀
4 · Reply
RAKIN13
RAKIN13 Dec. 11 at 8:01 PM
$ALLR when’s this stock going to explode??😅
3 · Reply
cfvk
cfvk Dec. 11 at 7:20 PM
$ALLR kind of surprised how well this has stayed over a dollar.
0 · Reply
Geo1313
Geo1313 Dec. 11 at 3:38 PM
$ALLR
0 · Reply
Ugly1
Ugly1 Dec. 10 at 11:55 PM
$ALLR RUN incoming…?
3 · Reply
Mahavatar
Mahavatar Dec. 10 at 9:35 PM
$ALLR waiting and still buying
0 · Reply
RunnerSignals
RunnerSignals Dec. 10 at 8:31 PM
1/4 Stock Upgrades Today $ALLR $OSTX $SNTI $PHR $RAPP Biotech bonanza incoming sky-high upside alert buckle up for gains https://stocksrunner.com/news/2025-12-10-stock-upgrades-today-show-top-picks
0 · Reply
jasonb1
jasonb1 Dec. 10 at 2:45 PM
$ALLR someone wants this lower. Yesterday wall was at 1.18 today 1.16 No one wants to sell this low though
1 · Reply
Nymn
Nymn Dec. 10 at 4:27 AM
$ALLR feel free to block me!! 👍👍 Jacka$$! 🤣🤣😂
0 · Reply
Latest News on ALLR
Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates

Nov 14, 2025, 9:00 AM EST - 4 weeks ago

Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates

Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months

Sep 22, 2025, 8:00 AM EDT - 2 months ago

Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months

Allarity Therapeutics CEO to Present at Biomarkers & Precision Medicine 2025

Sep 17, 2025, 8:00 AM EDT - 3 months ago

Allarity Therapeutics CEO to Present at Biomarkers & Precision Medicine 2025

Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer

Aug 26, 2025, 8:00 AM EDT - 3 months ago

Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

Aug 15, 2025, 4:30 PM EDT - 4 months ago

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization

Jul 15, 2025, 8:00 AM EDT - 5 months ago

Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization

Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer

Jul 7, 2025, 8:00 AM EDT - 5 months ago

Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer

Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer

Jun 27, 2025, 8:00 AM EDT - 6 months ago

Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer

Allarity Therapeutics Announces Changes to Board of Directors

Jun 11, 2025, 4:05 PM EDT - 6 months ago

Allarity Therapeutics Announces Changes to Board of Directors

Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment

May 9, 2025, 4:05 PM EDT - 7 months ago

Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment

ALLR Shareholders are Encouraged to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

Apr 14, 2025, 9:04 AM EDT - 8 months ago

ALLR Shareholders are Encouraged to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

ALLR Investors Have Opportunity to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

Mar 14, 2025, 4:30 AM EDT - 9 months ago

ALLR Investors Have Opportunity to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

Allarity Therapeutics Announces Final Settlement with the U.S. Securities and Exchange Commission

Mar 13, 2025, 8:30 AM EDT - 9 months ago

Allarity Therapeutics Announces Final Settlement with the U.S. Securities and Exchange Commission

Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination with Temozolomide for Recurrent Small Cell Lung Cancer Fully Funded by the US Veterans Administration

Mar 6, 2025, 8:00 AM EST - 10 months ago

Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination with Temozolomide for Recurrent Small Cell Lung Cancer Fully Funded by the US Veterans Administration

Allarity Therapeutics to Begin Enrollment for New Phase 2 Protocol to Advance Stenoparib Toward FDA Approval in Advanced Ovarian Cancer Patients

Feb 24, 2025, 8:00 AM EST - 10 months ago

Allarity Therapeutics to Begin Enrollment for New Phase 2 Protocol to Advance Stenoparib Toward FDA Approval in Advanced Ovarian Cancer Patients

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Feb 14, 2025, 10:00 AM EST - 10 months ago

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Shareholders to Inquire about Securities Investigation

Feb 13, 2025, 10:00 AM EST - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Shareholders to Connect

Feb 12, 2025, 10:00 AM EST - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Shareholders to Reach Out

Feb 11, 2025, 10:00 AM EST - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Stockholders to Inquire about Securities Investigation

Feb 10, 2025, 10:00 AM EST - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Allarity Therapeutics, Inc. (ALLR) and Encourages Investors to Learn More About the Investigation

Feb 9, 2025, 10:00 AM EST - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Allarity Therapeutics, Inc. (ALLR) and Encourages Investors to Learn More About the Investigation

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Feb 7, 2025, 10:00 AM EST - 11 months ago

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Investors to Connect

Feb 6, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Investors to Connect

Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer

Feb 6, 2025, 8:00 AM EST - 11 months ago

Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Investors to Inquire about Securities Investigation

Feb 4, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Investors to Reach Out

Feb 3, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Investors to Reach Out

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Stockholders to Reach Out

Feb 2, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Stockholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Stockholders to Connect

Jan 31, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Stockholders to Connect

Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC

Jan 30, 2025, 8:00 AM EST - 11 months ago

Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jan 8, 2025, 10:00 AM EST - 1 year ago

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Allarity Therapeutics, Inc. (ALLR) and Encourages Stockholders to Learn More About the Investigation

Jan 5, 2025, 10:00 AM EST - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Allarity Therapeutics, Inc. (ALLR) and Encourages Stockholders to Learn More About the Investigation

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements

Nov 18, 2024, 8:00 AM EST - 1 year ago

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics

Nov 11, 2024, 3:45 PM EST - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics

DEADLINE TOMORROW: Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Investors Are Invited To Reach Out To The Schall Law Firm

Nov 11, 2024, 11:15 AM EST - 1 year ago

DEADLINE TOMORROW: Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Investors Are Invited To Reach Out To The Schall Law Firm

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Invited To Contact The Schall Law Firm

Nov 9, 2024, 12:30 PM EST - 1 year ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Invited To Contact The Schall Law Firm

ALLR Deadline: Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Nov 8, 2024, 7:00 PM EST - 1 year ago

ALLR Deadline: Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics

Nov 8, 2024, 9:45 AM EST - 1 year ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Should Contact The Schall Law Firm

Nov 7, 2024, 11:00 AM EST - 1 year ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Should Contact The Schall Law Firm

The Schall Law Firm Encourages Stockholder Participation In A Case Against Allarity Therapeutics, Inc. For Fraud

Nov 6, 2024, 11:00 AM EST - 1 year ago

The Schall Law Firm Encourages Stockholder Participation In A Case Against Allarity Therapeutics, Inc. For Fraud

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Urged To Help The Schall Law Firm

Nov 4, 2024, 11:00 AM EST - 1 year ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Urged To Help The Schall Law Firm

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Urged To Contact The Schall Law Firm

Nov 2, 2024, 11:00 AM EDT - 1 year ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Urged To Contact The Schall Law Firm

The Schall Law Firm Invites Stockholders To Join A Lawsuit Against Allarity Therapeutics, Inc. For Fraud

Oct 29, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Invites Stockholders To Join A Lawsuit Against Allarity Therapeutics, Inc. For Fraud

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm

Oct 27, 2024, 11:00 AM EDT - 1 year ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm

papibaro
papibaro Dec. 12 at 8:12 PM
$ALLR sounds good. Byt I wonder how beneficial that is for allarity. As per chatgpt: I also wonder how accurate it is…
1 · Reply
MichaelSctock
MichaelSctock Dec. 12 at 6:10 PM
$ALLR Jensen is cookin’…. 👀
4 · Reply
RAKIN13
RAKIN13 Dec. 11 at 8:01 PM
$ALLR when’s this stock going to explode??😅
3 · Reply
cfvk
cfvk Dec. 11 at 7:20 PM
$ALLR kind of surprised how well this has stayed over a dollar.
0 · Reply
Geo1313
Geo1313 Dec. 11 at 3:38 PM
$ALLR
0 · Reply
Ugly1
Ugly1 Dec. 10 at 11:55 PM
$ALLR RUN incoming…?
3 · Reply
Mahavatar
Mahavatar Dec. 10 at 9:35 PM
$ALLR waiting and still buying
0 · Reply
RunnerSignals
RunnerSignals Dec. 10 at 8:31 PM
1/4 Stock Upgrades Today $ALLR $OSTX $SNTI $PHR $RAPP Biotech bonanza incoming sky-high upside alert buckle up for gains https://stocksrunner.com/news/2025-12-10-stock-upgrades-today-show-top-picks
0 · Reply
jasonb1
jasonb1 Dec. 10 at 2:45 PM
$ALLR someone wants this lower. Yesterday wall was at 1.18 today 1.16 No one wants to sell this low though
1 · Reply
Nymn
Nymn Dec. 10 at 4:27 AM
$ALLR feel free to block me!! 👍👍 Jacka$$! 🤣🤣😂
0 · Reply
Kvakklunch
Kvakklunch Dec. 10 at 3:54 AM
$ALLR @Nymn trying to speak about how stupid others are. What a joke. You are the one who is praying for a pump and still talking about your big fat bonus coming so not scared for a dump. LMAO TRASH! 🤡🤡🤡🤡 Morons like you make this board terrible.
1 · Reply
Nymn
Nymn Dec. 9 at 9:10 PM
$ALLR wow!! once again, SomePoop ( @somaopp ) demonstrates just how stupid he/she is. 🤦‍♂️ We’ve passed $1.95 more than once this year jacka$$ ! do a little DD as you’re shorting 🙄
0 · Reply
JarvisFlow
JarvisFlow Dec. 9 at 6:54 PM
Ascendiant Capital has updated their rating for Allarity Therapeutics ( $ALLR ) to Buy with a price target of 9.5.
3 · Reply
alibelmondo
alibelmondo Dec. 9 at 6:27 PM
$ALLR
0 · Reply
jasonb1
jasonb1 Dec. 9 at 4:20 PM
$ALLR let’s close today with a bullish hammer 
0 · Reply
somaopp
somaopp Dec. 9 at 3:24 PM
$ALLR $1 by eow??
0 · Reply
Kvakklunch
Kvakklunch Dec. 9 at 2:55 PM
$ALLR We are testing support at 1,00. Be careful
0 · Reply
MichaelSctock
MichaelSctock Dec. 9 at 6:03 AM
$ALLR overnight craziness
1 · Reply
Markshoemaker1
Markshoemaker1 Dec. 9 at 1:46 AM
$ALLR hurry up and come out with some new fat pill or some cure for people who take pills.
1 · Reply
Ugly1
Ugly1 Dec. 8 at 11:00 PM
$ALLR just blow up ($2-$3 range), let me out and then do your shelf offering. I might get back in later…once the dust settles. Idc -I’ll buy it on the up this time.
2 · Reply
MichaelSctock
MichaelSctock Dec. 8 at 9:08 PM
$ALLR more news this week. Run coming 👀 on my
0 · Reply
Popsiclestick
Popsiclestick Dec. 8 at 7:02 PM
$ALLR
0 · Reply